Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saline and budesonide middle nasal meatus drip irrigation after sinus surgery
ChiCTR2200055841Phase 4Not yet recruiting
- Sponsor
- People's Hospital of Tongliang District, Chongqing
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of budesonide in chronic rhinosinusitis (CRS) (3 arms), sponsored by People's Hospital of Tongliang District, Chongqing. Primary endpoints: Visual analog score and Endoscopic score. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
budesonide
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on ChiCTR2200055841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055841.